1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dogmi, AM; Al-Hazani, TMI; Al-Qahtani, WS; Alanazi, IS; Alhumaidi Alotaibi, M; Alneghery, LM; AlQassim, FA; Alshehri, E; Alwaili, MA; Jalal, AS; Safhi, FA | 1 |
| Kispert, S; Marentette, J; McHowat, J | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Patterns of mutations in nine cancer-related genes and PAF development among smoking male patients diagnosed with bladder cancer.
Topics: Humans; Male; Mutation; Non-Smokers; Platelet Activating Factor; Urinary Bladder Neoplasms | 2023 |
Cigarette smoking promotes bladder cancer via increased platelet-activating factor.
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Coculture Techniques; Endothelial Cells; Ginkgolides; Humans; Lactones; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Smoke; Tobacco Products; Up-Regulation; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2019 |